Cytokine Dysregulation in Chronic Kidney Disease: How Can We Treat It?

Publisher： Karger

E-ISSN： 1421-9735|26|3|291-299

ISSN： 0253-5068

Source： Blood Purification, Vol.26, Iss.3, 2008-04, pp. : 291-299

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Chronic Kidney Disease Management – What Can We Learn from South African and Australian Efforts?

By  

Blood Purification, Vol. 24, Iss. 1, 2005-12 ,pp. : 115-122

Karger

Access to resources Recommend Favorite

Use of Extended-Release Calcifediol to Treat Secondary Hyperparathyroidism in Stages 3 and 4 Chronic Kidney Disease

By  

American Journal of Nephrology, Vol. 44, Iss. 4, 2016-09 ,pp. : 316-325

Karger

Access to resources Recommend Favorite

Uromodulin and Chronic Kidney Disease

By  

Kidney and Blood Pressure Research, Vol. 33, Iss. 5, 2010-10 ,pp. : 393-398

Karger

Access to resources Recommend Favorite

Aging and Chronic Kidney Disease

By  

Kidney and Blood Pressure Research, Vol. 38, Iss. 1, 2014-03 ,pp. : 109-120

Karger

Access to resources Recommend Favorite

Targeting Glycosphingolipid Metabolism to Treat Kidney Disease

By  

Nephron, Vol. 134, Iss. 1, 2016-03 ,pp. : 37-42

Karger

Access to resources Recommend Favorite